fbpx

MedTech

SCIENTIFIC POSTER SUBMISSION

scientific abstract submission rules

We invite you to submit abstracts for our poster presentation which will be held on the 18th of November during Med-Tech World 2022.

Poster presenters will be offered free entrance to the whole conference however would need take care of their own travel and accommodation if travelling from abroad or otherwise.  

Theme: Health Informatics, Digital Health and Medical Technologies.   

How to Apply: 

  • Application process through online form 
  • Any questions should be addressed through contact form 

Privacy statement: SiGMA will use all personal information supplied as part of the abstract process to assess the abstract and to enable us to review the impact and equity of the process. Abstracts will be shared securely with a judging panel for the purpose of review. Successful abstracts will be kept on file until after the conference has taken place. 

Deadline for submission of abstracts: 5pm 30th September 2022  

Individuals may submit any number of abstracts as first author and/or appear on any number of abstracts as a co-author. You should only submit an abstract if the first author is able to and intends to attend the event to present the poster. Presentations must clearly relate to the abstract as submitted and the research described (where appropriate). Once an abstract has been accepted, if circumstances arise that prevent the first author from presenting you must inform us.

  • the content will likely be of interest to an adequate number of delegates  
  • the abstract is written so as to be understandable to delegates who may not have a research background; 
  • the significance of the poster outcome is clearly stated in the abstract; 
  • the methods appear to be adequate 
  • the results of the study are described in adequate detail and the conclusions in the abstract appear to be justified by the results presented. 
  • the abstract questions or potentially challenges conventional practice, through the uniqueness of the scenario or its outcome; 
  • the abstract highlights new information, or a unique treatment or management process, clinical governance structure or service delivery model; 

On submission of the abstract, the first named author must ensure that he/she has the approval and a copyright assignment from any other authors and contributors involved in the work.

Judges appointed will assess and judge scientific abstracts for poster presentations. To avoid any conflict of interest, a “blind” review process will be used. The decision is final.

Supported by

keep updated. subscribe to our newsletter.